Literature DB >> 8089683

Two species of antiganglioside antibodies in a patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome.

K Mizoguchi1, A Hase, T Obi, H Matsuoka, M Takatsu, Y Nishimura, F Irie, Y Seyama, Y Hirabayashi.   

Abstract

A patient with a pharyngeal-cervical-brachial variant of Guillain-Barré syndrome had anti-GT1a and anti-GD1a antibodies (IgG) in the serum. The activities of anti-GT1a antibodies were stronger than anti-GD1a antibodies and their activities declined later in the clinical course. These two different antibodies bound independently to each ganglioside in an absorption study with polystyrene beads coated with GT1a or GD1a.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8089683      PMCID： PMC1073141          DOI： 10.1136/jnnp.57.9.1121

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


  11 in total

1.  Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies.

Authors:  N Yuki; H Yoshino; S Sato; K Shinozawa; T Miyatake
Journal:  Muscle Nerve       Date:  1992-08       Impact factor: 3.217

2.  Isolation and characterization of a novel trisialoganglioside, GT1a, from human brain.

Authors:  S Ando; R K Yu
Journal:  J Biol Chem       Date:  1977-09-25       Impact factor: 5.157

3.  Serum antibodies to gangliosides in Guillain-Barré syndrome.

Authors:  A A Ilyas; H J Willison; R H Quarles; F B Jungalwala; D R Cornblath; B D Trapp; D E Griffin; J W Griffin; G M McKhann
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422

4.  Gangliosides of human spinal cord: aberrant composition of cords from patients with amyotrophic lateral sclerosis.

Authors:  G Dawson; K Stefansson
Journal:  J Neurosci Res       Date:  1984       Impact factor: 4.164

5.  Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies.

Authors:  A Chiba; S Kusunoki; H Obata; R Machinami; I Kanazawa
Journal:  Neurology       Date:  1993-10       Impact factor: 9.910

6.  Improved method for large-scale purification of brain gangliosides by Q-sepharose column chromatography. Immunochemical detection of C-series polysialogangliosides in adult bovine brains.

Authors:  Y Hirabayashi; T Nakao; M Matsumoto; K Obata; S Ando
Journal:  J Chromatogr       Date:  1988-07-22

7.  Gangliosides of human, cat, and rabbit spinal cords and cord myelin.

Authors:  K Ueno; S Ando; R K Yu
Journal:  J Lipid Res       Date:  1978-09       Impact factor: 5.922

8.  Characterization of N-glycolyneuraminic acid-containing glycosphingolipids from a Marek's disease lymphoma-derived chicken cell line, MSB1, as tumor-associated heterophile Hanganutziu-Deicher antigens.

Authors:  H Higashi; K Ikuta; S Ueda; S Kato; Y Hirabayashi; M Matsumoto; M Naiki
Journal:  J Biochem       Date:  1984-03       Impact factor: 3.387

9.  Motor neuropathy with activity of monoclonal IgM antibody to GD1a ganglioside.

Authors:  E Bollensen; H I Schipper; A J Steck
Journal:  J Neurol       Date:  1989-09       Impact factor: 4.849

10.  Unusual clinical variants and signs in Guillain-Barré syndrome.

Authors:  A H Ropper
Journal:  Arch Neurol       Date:  1986-11
View more
  13 in total

1.  Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.

Authors:  B Schwerer; A Neisser; H Bernheimer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Cranial and peripheral neuropathy due to Epstein-Barr virus infection.

Authors:  C Gavin; Y Langan; M Hutchinson
Journal:  Postgrad Med J       Date:  1997-07       Impact factor: 2.401

3.  Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes.

Authors:  Nortina Shahrizaila; Norito Kokubun; Setsu Sawai; Thirugnanam Umapathi; Yee-Cheun Chan; Satoshi Kuwabara; Koichi Hirata; Nobuhiro Yuki
Journal:  Neurology       Date:  2014-06-11       Impact factor: 9.910

4.  Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.

Authors:  J Schessl; M Koga; K Funakoshi; J Kirschner; W Muellges; A Weishaupt; R Gold; R Korinthenberg
Journal:  Arch Dis Child       Date:  2006-08-18       Impact factor: 3.791

5.  Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides.

Authors:  C P O'Leary; J Veitch; W F Durward; A M Thomas; J H Rees; H J Willison
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-12       Impact factor: 10.154

6.  Anti-GT1a IgG in Guillain-Barré syndrome.

Authors:  M Koga; H Yoshino; M Morimatsu; N Yuki
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

7.  Severe outcome of pharyngeal-cervical-brachial pure motor axonal neuropathy.

Authors:  L Bonanni; V Onofrj; V Scorrano; M Onofrj; A Thomas
Journal:  Open Neurol J       Date:  2010-01-29

8.  A Rare Form of Guillan Barre Syndrome: A Child Diagnosed with Anti-GD1a and Anti-GD1b Positive Pharyngeal-Cervical-Brachial Variant.

Authors:  Metin Uysalol; Burak Tatlı; Nedret Uzel; Agop Cıtak; Erhan Aygün; Semra Kayaoğlu
Journal:  Balkan Med J       Date:  2013-09-01       Impact factor: 2.021

Review 9.  Antiganglioside antibodies and their pathophysiological effects on Guillain-Barré syndrome and related disorders--a review.

Authors:  Kenichi Kaida; Toshio Ariga; Robert K Yu
Journal:  Glycobiology       Date:  2009-02-24       Impact factor: 4.313

Review 10.  Polyneuritis cranialis: oculopharyngeal subtype of Guillain-Barré syndrome.

Authors:  Benjamin R Wakerley; Nobuhiro Yuki
Journal:  J Neurol       Date:  2015-02-26       Impact factor: 4.849
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.